Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78M Sell
166,255
-82,564
-33% -$1.89M ﹤0.01% 2651
2026
Q1
$5.8M Sell
248,819
-122,613
-33% -$2.64M ﹤0.01% 2067
2025
Q4
$7.42M Sell
371,432
-364,301
-50% -$7.11M ﹤0.01% 2003
2025
Q3
$13.4M Sell
735,733
-285,877
-28% -$5.57M 0.01% 1452
2025
Q2
$20.5M Sell
1,021,610
-139,911
-12% -$2.69M 0.01% 1018
2025
Q1
$21.1M Buy
1,161,521
+318,874
+38% +$5.72M 0.02% 916
2024
Q4
$14.6M Buy
842,647
+184,595
+28% +$3.54M 0.01% 1245
2024
Q3
$12.7M Sell
658,052
-1,413
-0.2% -$26K 0.01% 1262
2024
Q2
$10.8M Sell
659,465
-75,265
-10% -$1.17M 0.01% 1284
2024
Q1
$11.2M Sell
734,730
-36,288
-5% -$570K 0.01% 1287
2023
Q4
$12.4M Buy
771,018
+60,395
+8% +$844K 0.01% 1221
2023
Q3
$9.23M Buy
710,623
+95,114
+15% +$1.24M 0.01% 1343
2023
Q2
$7.84M Sell
615,509
-70,699
-10% -$885K 0.01% 1538
2023
Q1
$7.72M Sell
686,208
-292,916
-30% -$3.55M 0.01% 1583
2022
Q4
$13M Buy
979,124
+46,803
+5% +$615K 0.01% 1213
2022
Q3
$10.8M Sell
932,321
-221,413
-19% -$3.04M 0.01% 1286
2022
Q2
$17M Sell
1,153,734
-58,528
-5% -$959K 0.02% 980
2022
Q1
$23.5M Buy
1,212,262
+413,269
+52% +$7.38M 0.02% 923
2021
Q4
$13.8M Sell
798,993
-27,107
-3% -$462K 0.01% 1385
2021
Q3
$13.8M Sell
826,100
-9,759
-1% -$146K 0.01% 1271
2021
Q2
$11.2M Sell
835,859
-213,539
-20% -$2.67M 0.01% 1398
2021
Q1
$12.5M Sell
1,049,398
-95,123
-8% -$1.15M 0.01% 1216
2020
Q4
$14.2M Sell
1,144,521
-90,447
-7% -$976K 0.01% 1159
2020
Q3
$12.9M Sell
1,234,968
-116,709
-9% -$1.48M 0.01% 1073
2020
Q2
$18.9M Sell
1,351,677
-183,418
-12% -$2.49M 0.02% 816
2020
Q1
$18.1M Sell
1,535,095
-153,310
-9% -$2.03M 0.03% 670
2019
Q4
$23.9M Buy
1,688,405
+150,974
+10% +$1.85M 0.03% 727
2019
Q3
$16.2M Sell
1,537,431
-420,301
-21% -$5.03M 0.02% 876
2019
Q2
$28.5M Sell
1,957,732
-178,386
-8% -$2.53M 0.04% 584
2019
Q1
$30M Buy
2,136,118
+179,798
+9% +$2.91M 0.04% 542
2018
Q4
$34.1M Buy
1,956,320
+1,001,636
+105% +$16.3M 0.05% 472
2018
Q3
$14.5M Buy
954,684
+482,603
+102% +$6.95M 0.02% 922
2018
Q2
$6.51M Buy
472,081
+276,624
+142% +$4.14M 0.01% 1345
2018
Q1
$3.26M Sell
195,457
-379,035
-66% -$5.85M ﹤0.01% 1699
2017
Q4
$8.15M Sell
574,492
-297,091
-34% -$3.96M 0.01% 1157
2017
Q3
$12.3M Buy
871,583
+151,340
+21% +$2M 0.02% 818
2017
Q2
$9.22M Sell
720,243
-447,695
-38% -$5.62M 0.02% 950
2017
Q1
$16.2M Buy
1,167,938
+549,932
+89% +$6.47M 0.03% 676
2016
Q4
$6.61M Sell
618,006
-190,430
-24% -$2M 0.01% 1195
2016
Q3
$8.88M Buy
808,436
+304,793
+61% +$3.56M 0.02% 957
2016
Q2
$5.3M Buy
503,643
+100,686
+25% +$1.19M 0.01% 1251
2016
Q1
$5.07M Buy
402,957
+152,255
+61% +$1.67M 0.01% 1263
2015
Q4
$2.64M Buy
250,702
+210,861
+529% +$1.94M ﹤0.01% 1910
2015
Q3
$286K Sell
39,841
-97,664
-71% -$1.33M ﹤0.01% 3367
2015
Q2
$2.48M Sell
137,505
-58,232
-30% -$1M ﹤0.01% 2020
2015
Q1
$3.08M Sell
195,737
-468
-0.2% -$7.08K ﹤0.01% 1716
2014
Q4
$2.78M Sell
196,205
-422,594
-68% -$6.35M ﹤0.01% 2005
2014
Q3
$10.6M Buy
618,799
+246,352
+66% +$5.66M 0.01% 1045
2014
Q2
$11.1M Buy
372,447
+30,540
+9% +$732K 0.02% 1028
2014
Q1
$8.52M Buy
341,907
+28,351
+9% +$830K 0.01% 1157
2013
Q4
$9.01M Buy
313,556
+57,190
+22% +$1.67M 0.01% 1220
2013
Q3
$8.45M Buy
+256,366
New +$7.97M 0.01% 1159

Other funds holding INVA

David Shaw's INVA Position: Q2 2026 in Review

David Shaw reduced its Innoviva (INVA) stake by 33% in Q2 2026, selling an estimated $1.89M and leaving 166,255 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

David Shaw first reported a position in INVA in Q3 2013 and has held it in 52 quarters since. The position peaked at $34.1M in Q4 2018. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • David Shaw held 166,255 shares of Innoviva worth $3.78M as of Q2 2026.
  • David Shaw sold 82,564 Innoviva shares in Q2 2026, an estimated $1.89M.
  • Innoviva made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2651 holding.
  • David Shaw first reported a position in Innoviva in Q3 2013 and has held it in 52 quarters since.
  • David Shaw's Innoviva position peaked at $34.1M in Q4 2018.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.